These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15854070)

  • 1. Frequency doubling technology perimetry and standard automated perimetry in migraine.
    Harle DE; Evans BJ
    Ophthalmic Physiol Opt; 2005 May; 25(3):233-9. PubMed ID: 15854070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of frequency doubling technology perimetry and achromatic standard automated perimetry in patients with migraine without aura and controls].
    Göbel K; Boyraz M; Schröder A; Erb C
    Klin Monbl Augenheilkd; 2008 Aug; 225(8):718-22. PubMed ID: 18712657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
    Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
    J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humphrey matrix frequency doubling perimetry for detection of visual-field defects in open-angle glaucoma.
    Clement CI; Goldberg I; Healey PR; Graham S
    Br J Ophthalmol; 2009 May; 93(5):582-8. PubMed ID: 18669543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of spatial-contrast function and short-wavelength sensitivity deficits in patients with migraine.
    Yenice O; Onal S; Incili B; Temel A; Afşar N; Tanridağ T
    Eye (Lond); 2007 Feb; 21(2):218-23. PubMed ID: 16456594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.
    Bozkurt B; Yilmaz PT; Irkec M
    J Glaucoma; 2008; 17(3):203-10. PubMed ID: 18414106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detectability of glaucomatous changes using SAP, FDT, flicker perimetry, and OCT.
    Nomoto H; Matsumoto C; Takada S; Hashimoto S; Arimura E; Okuyama S; Shimomura Y
    J Glaucoma; 2009 Feb; 18(2):165-71. PubMed ID: 19225357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
    Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
    Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cataract extraction on frequency doubling technology perimetry.
    Kook MS; Yang SJ; Kim S; Chung J; Kim ST; Tchah H
    Am J Ophthalmol; 2004 Jul; 138(1):85-90. PubMed ID: 15234286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frequency doubling perimetry in diagnosis of early glaucomatous optic nerve fiber damage].
    Korzekwa W; Korzekwa M; Markowska J; Wójcik-Niklewska B; Romaniuk W; Korzekwa A; Michalska-Małecka K
    Klin Oczna; 2004; 106(1-2 Suppl):222-4. PubMed ID: 15510506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?
    Ferreras A; Polo V; Larrosa JM; Pablo LE; Pajarin AB; Pueyo V; Honrubia FM
    J Glaucoma; 2007; 16(4):372-83. PubMed ID: 17571000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucomatous visual field defects in patients with migraine.
    Comoğlu S; Yarangümeli A; Köz OG; Elhan AH; Kural G
    J Neurol; 2003 Feb; 250(2):201-6. PubMed ID: 12574951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humphrey matrix frequency doubling technology perimetry and optical coherence tomography measurement of the retinal nerve fiber layer thickness in both normal and ocular hypertensive subjects.
    Mastropasqua L; Brusini P; Carpineto P; Ciancaglini M; Di Antonio L; Zeppieri MW; Parisi L
    J Glaucoma; 2006 Aug; 15(4):328-35. PubMed ID: 16865011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of SITA and full-threshold standard perimetry to frequency-doubling technology perimetry in glaucoma.
    Boden C; Pascual J; Medeiros FA; Aihara M; Weinreb RN; Sample PA
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2433-9. PubMed ID: 15980232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability of frequency doubling technology perimetry (20-1 screening program) and the effect of pupillary dilatation on interpretation.
    Parikh R; Muliyil J; George R; Bhat S; Thomas R
    Ophthalmic Epidemiol; 2008; 15(1):42-6. PubMed ID: 18300088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning effect of humphrey matrix frequency doubling technology perimetry in patients with ocular hypertension.
    Centofanti M; Fogagnolo P; Oddone F; Orzalesi N; Vetrugno M; Manni G; Rossetti L
    J Glaucoma; 2008 Sep; 17(6):436-41. PubMed ID: 18794676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of test duration as a screening criterion for frequency doubling perimetry.
    Thomas R; Parikh R; Muliyil J; Bhat S; George R
    Am J Ophthalmol; 2004 Mar; 137(3):562-3. PubMed ID: 15013885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual field testing with the new Humphrey Matrix: a comparison between the FDT N-30 and Matrix N-30-F tests.
    Brusini P; Salvetat ML; Zeppieri M; Tosoni C; Parisi L; Felletti M
    Acta Ophthalmol Scand; 2006 Jun; 84(3):351-6. PubMed ID: 16704697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.